EP3222724

SILENCE THERAPEUTICS GMBH
Application Number
EP17160954A
Filing Date
Aug 5, 2003
Status
Granted And Under Opposition
Sep 28, 2018
Grant Date
Oct 31, 2018
External Links
Slate, Register

Biblio Summary

The patent EP3222724B1 was granted on Oct 31, 2018 by Silence Therapeutics Gmbh The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALNYLAM PHARMACEUTICALS INC.Oct 31, 2018WITHDRAWN

The table below shows the patents of Silence Therapeutics Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3607069Products And CompositionsNov 2, 20221
EP1857547Further Novel Forms Of Interfering Rna MoleculesDec 2, 20203
EP2258847Futher Novel Forms Of Interfering Rna MoleculesJul 1, 20203